Milan, Italy

Mauro Filippi

This inventor holds 1 USPTO granted patent. Top assignee: Ortho-Mcneil Pharmaceutical Corp.. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mauro Filippi. Retrieved from https://idiyas.com/inventor/mauro-filippi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Mauro Filippi

Introduction

Mauro Filippi is a notable inventor based in Milan, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antibiotics. His work has led to the creation of innovative compounds that have the potential to enhance medical treatments.

Latest Patents

Mauro Filippi holds a patent for "Aminothiazole derivatives useful in the preparation of β-lactam antibiotics." This patent focuses on aminothiazole derivatives that are activated by thioesters, which can be condensed with β-lactam nuclei to yield effective β-lactam antibiotics. This innovation represents a crucial advancement in antibiotic development.

Career Highlights

Filippi is associated with Ortho-McNeil Pharmaceutical Corporation, where he has been instrumental in research and development. His expertise in medicinal chemistry has allowed him to contribute to the advancement of pharmaceutical sciences.

Collaborations

Mauro Filippi has worked alongside talented colleagues such as Maurizio Zenoni and Maurizio Serra. Their collaborative efforts have fostered an environment of innovation and creativity within their projects.

Conclusion

Mauro Filippi's contributions to the field of pharmaceuticals, particularly through his patent on aminothiazole derivatives, highlight his role as an influential inventor. His work continues to impact the development of essential medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…